aiweekly

Georgia Tech's RCWM Turns Single Images Into Recursive Scene Code

Georgia Tech researchers Zhiqi Li, Yuxuan Liao, and Bo Zhu introduce Recursive Code World Models (RCWM), a framework that reconstructs 3D worlds ...
coinedition

Vitalik Buterin Proposes Recursive STARKs for Ethereum’s I-Star Upgrade

Vitalik Buterin proposes recursive STARKs for Ethereum’s I-Star upgrade, aiming to cut computing costs and support new ...
finance.biggo

Kevin Madura: The Next Big Leap Isn't a Better Model — It's Teaching AI to Manage Its Own Memory

While the industry obsesses over faster chips and bigger context windows, AlixPartners consultant Kevin Madura argues the real disruption ...
stockstotrade

RXRX Tightens Cash Burn As AI Drug Pipeline Advances

Recursion Pharmaceuticals Inc. surged as investors cheered its latest AI-driven drug discovery breakthrough; stocks have been ...
BroadwayWorld

Eunji Lim To Star In THE RECURSION OF A MOTH at Teatro Círculo

Eunji Lim will lead the cast of THE RECURSION OF A MOTH, a new play by Brandon Zang directed by Seonjae Kim, at Teatro ...
Condé Nast Traveler

What Rockaway Film Festival Can Teach Us About Going to the Movies

I arrive at this year’s Rockaway Film Festival (RFF9) in local uniform, with swim trunks donned beneath my work slacks and ...

Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?

Recursion Pharmaceuticals is expanding its clinical pipeline across oncology and rare diseases, with REC-4881 and multiple programs offering potential growth catalysts.

The Market Just Told You Which Layer Of AI Biology It Is Paying For

The connected representation of biology those models run on is built once and curated for decades. MindWalk Holdings Corp. is selling the second thing. Twenty years of curation, quantified. HYFT® ...
BroadwayWorld

THE RECURSION OF A MOTH to Open at Teatro Círculo's Second Stage

Cellunova Productions will present a workshop production of the AANHPI science-fiction play, written by Brandon Zang and ...
BioSpace

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...